| Gout (n = 226) |  |
---|---|---|
Comorbiditiesb | ||
 Hypertension | 96 (42.5) |  |
 DM | 23 (10.2) |  |
 Hyperlipidemia | 25 (11.1) |  |
 Cardiovascular disease | 22 (9.7) |  |
 Nephropathy | 17 (7.5) |  |
 Disease duration (year)C | 5 (2–12) |  |
 Number of flares/last yearC | 3 (1.25–12) |  |
Stage of goutb | ||
 Asymptomatic (hyperuricemia) | 8 (3.5) |  |
 Acute phase | 128 (56.6) |  |
 Intercritical phase | 37 (16.4) |  |
 Chronic phase | 53 (23.5) |  |
Number of tophib | ||
 No | 136 (60.2) |  |
 1 | 37 (16.4) |  |
  ≥ 2 | 53 (23.5) |  |
sUA (μmol/L)a | 468.15 ± 116.59 |  |
Presence of tender joints, yesb | 190 (84.1) | Â |
Presence of swollen joints, yesb | 162 (71.7) | Â |
Total pain (VAS)C | 4.25(0–7.75) |  |
Urate lowering therapyb | ||
 Allopurinol | 16 (7.1) |  |
 Febuxostat | 80 (35.4) |  |
Any anti-inflammatory drugsb | ||
 Colchicine | 146 (64.6) |  |
 NSAID | 105 (46.5) |  |
 Corticosteroids | 71 (31.4) |  |